Within Quay Pharma we can provide virtually all of the services required to bring drug products through the various stages of clinical development quickly and cost-effectively.
Quay Pharma has the expertise to give each product the best possible chance of success by optimising its delivery mechanism. Our experienced analytical team is on hand to provide all the support required through each stage of development and manufacture.
With clearly set out costs for specific stages, our cost structure is transparent and we can contribute from the preclinical stage, formulation, dosage form development and optimisation. In addition, we can provide a full manufacturing and packaging service covering Phase I, Phase II and small-scale Phase III from our accredited GMP facilities.
By drawing on our considerable experience of developing new dosage forms for new indications or different patient populations, we can also help organisations who want to reformulate or reposition existing drug products using our services. In addition, our GMP capabilities can be used for scale-up manufacturing, specials manufacturing and even small-scale commercial manufacturing.